UBDS Digital Secures $5.0M

Oxford Drug Design

Oxford Drug Design, an advanced spinout from Oxford University, is an innovative biotechnology company discovering and developing novel therapeutics supported by pioneering computational methods. We design innovative drugs with differentiated modes of action against cancer and other challenging diseases with high unmet medical need seeking superior patient outcomes. Based on the unique integration of our dual core competences in aminoacyl-tRNA synthetase enzymes and distinctive AI/ML methods, our pipeline expansion is focused on oncology. This distinctive drug discovery platform has been validated by the rapid discovery of novel therapeutic candidates with highly innovative chemical scaffolds and modes of action.

Dartle

Dartle is a sports technology platform that offers a suite of tools and services to sports academies to manage their operations and track athlete performance data. The platform is built using modern cloud technologies and offers a highly secure, scalable, and reliable solution to its customers. Dartle uses machine learning algorithms to analyze performance data and provides actionable insights to academies to help them optimize their athlete development programs. The platform also enables academies to create historical performance portfolios for their athletes, which can be used by recruiters to discover new talent. The platform is highly configurable and can be easily customized to meet the specific needs of each academy. Overall, Dartle is a powerful and flexible platform that can help sports academies streamline their operations and achieve better performance outcomes. Dartle provides sports academies with a system that allows to manage their operations while also giving them a flexible framework for long term athlete development and data capture. Our analytics then helps academies to improve the performance of their young athletes. As a consequence, a historical performance portfolio for a player is created which moves with the player across academies and also allows for player's global visibility

Conduct

Conduct’s mission is to make IT the innovation powerhouse of every company. Our agentic AI delivers an in-depth understanding of legacy enterprise software. For the first time ever, you can chat directly with your systems to resolve major business issues in days instead of months. We’re starting where it matters most: SAP, the OS of global business. Conduct makes the unmanageable, manageable. Setting the stage for the next era of productivity growth with AI-powered Enterprise System Intelligence.

Ovum

Please follow our new company page Omdia.

Zodia Custody

Zodia Custody is an institution-first digital assets platform backed by Standard Chartered, in association with Northern Trust, SBI Holdings, National Australia Bank, and Emirates NBD. Combining deep expertise in financial services, compliance, risk, and technology, Zodia Custody enables institutional investors around the globe to realise the full potential of the digital assets future – simply, safely, and without compromise. It operates under registrations and authorisations granted by the Financial Conduct Authority, Central Bank of Ireland, Commission de Surveillance du Secteur Financier, and Hong Kong Companies Registry.